Remdesivir Shows Promise as COVID-19 Treatment

Results from a National Institutes of Health clinical trial of the Gilead anti-viral Remdesivir in advanced COVID-19 are in, and they are promising.

The trial (known as the Adaptive COVID-19 Treatment Trial, or ACTT), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID…